1
Return

Tissue-Specific Silencing of Synthetic mRNAs By De-Targeting Elements Maps Vaccination-Competent Tissues, and Allows Cas9 De-Immunization

delete2026-07-29
delete0
delete
OA
AI
G
Guendalina Froechlich
A
Annagiulia Scognamiglio
L
Linda Nocchi
E
Emilio Pellino
A
Andrea Campanile
L
Luigia Infante
G
Giulio Miano
A
Alessandra Centore
F
Francesco Molfetta
A
Alessandra Napolano
A
Anna Morena D’Alise
S
Silvia Parisi
A
Alfredo Nicosia
E
Emanuele Sasso *
N
Nicola Zambrano *
DOI:10.1016/j.ymthe.2026.07.050delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
The clinical success of mRNA/LNP-based vaccines has established a leading platform for in vivo nucleic acid delivery, yet the relationship between biodistribution, tissue-specific translation, and immune activation remains poorly defined. Here, we systematically investigate the anatomical determinants of immune responses elicited by mRNA/LNPs. Using a gold-standard LNP formulation, we map exogenous mRNA biodistribution and functionally interrogate the contribution of distinct organs to both humoral and cellular immunity. To achieve this, we engineered mRNAs containing 3'-UTR embedded de-targeting elements as target sites for endogenous tissue-specific microRNAs, enabling selective silencing of antigen expression in defined anatomical compartments. This approach allowed us to causally link sites of translation with immune outputs. Applying this strategy to a Spike-based vaccine model, we identify muscle and spleen as the most immunologically competent tissues required for robust immune priming. These findings provide a framework for the rational design of next-generation mRNA/LNP formulations with enhanced targeting precision, enabling dose sparing and reduced off-target effects. Furthermore, we extended this concept to genome editing by preventing mRNA-Cas9 expression in immune active tissues, thereby reducing its immunogenicity and toxicity. Collectively, our work establishes a unifying strategy to optimize both potency and safety of mRNA-based therapeutics.
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Molecular Therapy cover
Molecular Therapy
IF:
12
Papers:
9.9K
Citations:
3.0W

Organization

U
università degli studi di napoli federico ii
Scholars:
170
Papers: 67
Citations: 2
Cited Papers

Cited Papers

Citing Papers

Citing Papers